The Edit Review: $209 Semaglutide, Cancel Anytime

The Edit (theedithealth.com) is a Texas management services organization selling six compounded protocols, five of them injectable. We read its published prices in August 2026 as part of a batch of seven telehealth sellers screened together. If you are treating insulin resistance rather than chasing a number on a scale, the useful question about a program is not what the first month costs. It is whether the price survives a year of titration, whether the medication keeps arriving while it does, and whether you can stop in month three without owing anyone anything. The Edit is the only one of the seven whose published answer to all three held up to arithmetic.

What you would actually be billed

Semaglutide is $209 a month. Tirzepatide is $309 a month. Those are the standing recurring rungs, with no membership fee stacked on top, no minimum term, and cancellation taking effect at the end of the period you have already paid for.¹ Prepay exists as a separate, clearly labeled option — $575 billed once for three months of semaglutide, $1,065 once for six; $855 for three months of tirzepatide, $1,575 for six.¹

Every one of those prepay totals divides correctly into the per-month figure printed beside it: 575 over three is 191.67, 1,065 over six is 177.50, 855 over three is 285, 1,575 over six is 262.50. That reads like faint praise until you have seen the alternative. The most common way a telehealth seller reaches the cheap end of a comparison table is a prepay total displayed as though it were a monthly rate, and we take one such program apart tier by tier in our guide to what GLP-1 costs. The Edit does not do it.

The dose column that is not there

The Edit publishes one monthly figure per protocol and no per-dose rungs anywhere on either surface we read. That is not the same thing as a written promise that the price holds at every titration step — Trellis Vitality states that in words on its own pricing table, where The Edit simply never shows a dose column. Absence of a dose ladder is weaker evidence than a stated flat price, and we file it as such. It is still worth more than a published ladder that climbs, because a climbing ladder is the mechanism by which a program that looked affordable at 0.25 mg stops being affordable at the dose that was actually doing something.

The $109 on the homepage is a promotion

The Edit advertises semaglutide at $109 and tirzepatide at $209 for a first order. That is $100 off the first month, not a standing rate. Budget on $209 and $309, or on the prepay totals. This distinction is the whole reason we file recurring rungs rather than advertised ones, and it is why our numbers rarely match the figure on any provider's own hero banner.

Who signs the prescription, and who fills it

Clinical work is done by Arora Health & Aesthetics, LLC, whose medical director is Dr. Sean Arora. His NPI, 1841729449, resolves in the national registry to an active Family Medicine record in Seattle, Washington.² Dispensing is attributed to a named pharmacy, The Pharmacy Hub, rather than to an unnamed "partner pharmacy". Naming a prescriber you can look up and naming the pharmacy that fills the vial are the two checks that most of this cohort fails; The Edit passes both, which is the standard our checklist for judging a program before you pay is built around.

One caveat before you treat this as an independent second opinion. Trellis Vitality uses the same medical group and the same medical director. Different pharmacy, different prices, genuinely different catalogs — but if you shortlist both, you have shortlisted one clinical organization twice rather than compared two.

What the FDA screen returned

We queried the FDA's live warning-letter index in August 2026 for the company, for its legal entity, for its medical group and for its named pharmacy. Nothing matched in the company column.³ That result is only meaningful because the same pass, run the same way, correctly returned a known 2026 letter for an unrelated telehealth seller used as a positive control — an empty result from a broken query is indistinguishable from a clean record, which is why the control is the part that matters.

What we could not verify

We could not reach a checkout price. The intake is a questionnaire-walled flow whose scripts carry no price table, so the ladder above is the published ladder corroborated across two independent surfaces on the provider's own site, not a figure confirmed at the point of sale. Compounded medication is final sale once shipped, which is standard for the category and explained in our compounded versus brand-name guide. Starting is free: the site states there is no charge and no card on file to begin, and a full refund if you are not approved. The Edit also ships a complete Spanish mirror of every page — 33 Spanish URLs in its own sitemap — which is rare enough to be worth naming, and material if Spanish is the language you want dosing instructions in.

Where it lands for a metabolic-health reader

The Edit is not the cheapest of the seven. Pepti lists semaglutide at $99 and Trellis at $150, and Auren Rx at $199. It is the one whose numbers survived every check we ran, sold with no membership, no minimum and no penalty for stopping — which is what continuity actually costs. Read it against the mechanism in our guide to insulin resistance and GLP-1 medicines, and against the rubric on our Luna Fit Score methodology page. The Edit is not scored on that rubric: it is not in our ranking, we have no commercial relationship with it, and this write-up exists because a reader comparing programs deserves the numbers either way.